ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. TMUS
9. UNP
10. GOOGL

Go back to ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
(NASDAQ: PRQR) Delayed: 1.72 -0.07 (3.91%)
Previous Close $1.79    52 Week High $13.33 
Open $1.79    52 Week Low $3.48 
Day High $1.84    P/E N/A 
Day Low $1.70    EPS $0.00 
Volume 567,331